Neurogenic inflammation: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) No edit summary |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 29: | Line 29: | ||
*[http://content.nejm.org/cgi/content/full/352/18/1899 Psoriasis: Neurogenic inflammation and other mechanisms] Psoriasis, a common inflammatory skin disorder. | *[http://content.nejm.org/cgi/content/full/352/18/1899 Psoriasis: Neurogenic inflammation and other mechanisms] Psoriasis, a common inflammatory skin disorder. | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
Latest revision as of 14:16, 20 August 2012
| Neurogenic inflammation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Neurogenic inflammation is a general term used to describe the local release of inflammatory mediators from afferent neurons such as substance P and calcitonin gene-related peptide.
Pathophysiology
This process appears to play an important role in the pathogenesis of numerous diseases including asthma, fibromyalgia, eczema, psoriasis and migraine.
External links
- Bronchial Asthma as Neurogenic Inflammatory Paroxysmal Disease Common neurogenic inflammatory mechanisms of asthma with migraine and trigeminal neuralgia.
- Psoriasis: Neurogenic inflammation and other mechanisms Psoriasis, a common inflammatory skin disorder.